Baseline patient reported outcomes in patients with peripheral artery disease and type 2 diabetes from STRIDE: a phase 3, 52-week, randomised, double-blind, placebo-controlled trial

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Peripheral artery disease: risk factors Peripheral Artery Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by